Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

446 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Unlocking antitumor immunity with adenosine receptor blockers.
Remley VA, Linden J, Bauer TW, Dimastromatteo J. Remley VA, et al. Among authors: bauer tw. Cancer Drug Resist. 2023 Oct 25;6(4):748-767. doi: 10.20517/cdr.2023.63. eCollection 2023. Cancer Drug Resist. 2023. PMID: 38263981 Free PMC article. Review.
Mobile sensing to advance tumor modeling in cancer patients: A conceptual framework.
Chow PI, Roller DG, Boukhechba M, Shaffer KM, Ritterband LM, Reilley MJ, Le TM, Kunk PR, Bauer TW, Gioeli DG. Chow PI, et al. Among authors: bauer tw. Internet Interv. 2023 Jul 8;34:100644. doi: 10.1016/j.invent.2023.100644. eCollection 2023 Dec. Internet Interv. 2023. PMID: 38099095 Free PMC article.
Recurrent Intrahepatic Cholangiocarcinoma: A 10-Point Score to Predict Post-Recurrence Survival and Guide Treatment of Recurrence.
Tsilimigras DI, Endo Y, Guglielmi A, Aldrighetti L, Weiss M, Bauer TW, Popescu I, Poultsides GA, Maithel SK, Marques HP, Martel G, Pulitano C, Shen F, Cauchy F, Koerkamp BG, Endo I, Pawlik TM. Tsilimigras DI, et al. Among authors: bauer tw. Ann Surg Oncol. 2024 Mar 23. doi: 10.1245/s10434-024-15210-2. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38520582
A histone methylation-MAPK signaling axis drives durable epithelial-mesenchymal transition in hypoxic pancreatic cancer.
Brown BA, Myers PJ, Adair SJ, Pitarresi JR, Sah-Teli SK, Campbell LA, Hart WS, Barbeau MC, Leong K, Seyler N, Kane W, Lee KE, Stelow E, Jones M, Simon MC, Koivunen P, Bauer TW, Stanger BZ, Lazzara MJ. Brown BA, et al. Among authors: bauer tw. Cancer Res. 2024 Mar 12. doi: 10.1158/0008-5472.CAN-22-2945. Online ahead of print. Cancer Res. 2024. PMID: 38471099
The complication-overall survival (CompOS) risk tool predicts risk of a severe postoperative complications relative to long-term survival among patients with primary liver cancer.
Endo Y, Tsilimigras DI, Woldesenbet S, Marques HP, Cauchy F, Weiss M, Bauer TW, Poultsides GA, Maithel SK, Kitago M, Alexandrescu S, Martel G, Guglielmi A, Pulitano C, Gleisner A, Hugh T, Aldrighetti L, Shen F, Koerkamp BG, Endo I, Pawlik TM. Endo Y, et al. Among authors: bauer tw. J Gastrointest Surg. 2024 Feb;28(2):132-140. doi: 10.1016/j.gassur.2023.12.010. Epub 2024 Feb 5. J Gastrointest Surg. 2024. PMID: 38445934
Predicting risk of recurrence after resection of stage I intrahepatic cholangiocarcinoma.
Kawashima J, Sahara K, Shen F, Guglielmi A, Aldrighetti L, Weiss M, Bauer TW, Alexandrescu S, Poultsides GA, Maithel SK, Marques HP, Martel G, Pulitano C, Cauchy F, Koerkamp BG, Matsuyama R, Endo I, Pawlik TM. Kawashima J, et al. Among authors: bauer tw. J Gastrointest Surg. 2024 Jan;28(1):18-25. doi: 10.1016/j.gassur.2023.10.002. J Gastrointest Surg. 2024. PMID: 38353070
446 results